1. 4CPS-023 Long term efficacy, safety and adherence to alirocumab in patients with dyslipidaemia from a tertiary hospital cohort. (24th March 2020) Authors: Rodriguez, A; Lopez, C; González-Colominas, E; Luque, S; Recasens, L; Pedro-Botet, J; Oliveras, A; Gonzalez, R; Tarason, L; Grau, S Journal: European journal of hospital pharmacy Issue: Volume 27(2020)Supplement 1 Page Start: A57 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 4CPS-024 Efficacy, safety and acceptance of treatment with alirocumab or evolocumab in patients with dyslipidaemia. (March 2019) Authors: Monge, I; Acin, P; Navarrete-Rouco, E; Recasens, L; Pedro-Botet, J; Oliveras, A; González-Colominas, E; Luque, S; Grau, S Journal: European journal of hospital pharmacy Issue: Volume 26(2019)Supplement 1 Page Start: A78 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. High prevalence of cardiovascular co-morbidities in patients with symptomatic knee or hand osteoarthritis. (2nd January 2016) Authors: Calvet, J; Orellana, C; Larrosa, M; Navarro, N; Chillarón, JJ; Pedro-Botet, J; Galisteo, C; García-Manrique, M; Gratacós, J Journal: Scandinavian journal of rheumatology Issue: Volume 45:Number 1(2016) Page Start: 41 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗